Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes
Authors:
Open Access
- 11 July 2022
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 36 (8) , e22443
Abstract
Barth Syndrome (BTHS) is a rare X‐linked genetic disorder caused by mutation in the TAFAZZIN gene. Tafazzin (Taz) deficiency in BTHS patients results in an increased risk of infections. Mesenchymal stem cells (MSCs) are well known for their immune‐inhibitory function. We examined how Taz‐deficiency in murine MSCs impact their ability to modulate the function of lipopolysaccharide (LPS)‐activated wild type (WT) B lymphocytes. MSCs from tafazzin knockdown (TazKD) mice exhibited a reduction in mitochondrial cardiolipin compared to wild type (WT) MSCs. However, mitochondrial bioenergetics and membrane potential were unaltered. In contrast, TazKD MSCs exhibited increased reactive oxygen species generation and increased glycolysis. The increased glycolysis was associated with an elevated proliferation, phosphatidylinositol‐3‐kinase expression and expression of the immunosuppressive markers indoleamine‐2,3‐dioxygenase, cytotoxic T‐lymphocyte‐associated protein 4, interleukin‐10, and cluster of differentiation 59 compared to controls. Inhibition of glycolysis with 2‐deoxyglucose attenuated the TazKD‐mediated increased expression of cytotoxic T‐lymphocyte‐associated protein 4 and interleukin‐10. When co‐cultured with LPS‐activated WT B cells, TazKD MSCs inhibited B cell proliferation and growth rate and reduced B cell secretion of immunoglobulin M compared to controls. In addition, co‐culture of LPS‐activated WT B cells with TazKD MSCs promoted B cell differentiation toward interleukin‐10 secreting plasma cells and B regulatory cells compared to controls. The results indicate that Taz deficiency in MSCs promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes.Keywords
All Related Versions
Funding Information
- Canada Research Chairs
- Institute of Infection and Immunity
- Natural Sciences and Engineering Research Council of Canada
- Children's Hospital Research Institute of Manitoba
- University of Manitoba
This publication has 63 references indexed in Scilit:
- Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated DamagePLOS ONE, 2013
- Barth syndromeOrphanet Journal of Rare Diseases, 2013
- Making heads or tails of phospholipids in mitochondriaJournal of Cell Biology, 2011
- Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth SyndromeJournal of Biological Chemistry, 2011
- Mesenchymal stem cells suppress B-cell terminal differentiationExperimental Hematology, 2009
- CTLA-4 Activation of Phosphatidylinositol 3-Kinase (PI 3-K) and Protein Kinase B (PKB/AKT) Sustains T-Cell Anergy without Cell DeathPLOS ONE, 2008
- B lymphocytes: how they develop and functionBlood, 2008
- Mesenchymal Stem Cells – Sources and Clinical ApplicationsTransfusion Medicine and Hemotherapy, 2008
- The riddle of the dual expression of IgM and IgDImmunology, 2006
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976